OutSee raises £1.8M seed funding to expand therapeutic pipeline using predictive genomics
- Financing led by Ahren Innovation Capital with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures
- Investment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and progress in-house target development program
